DDW: Diabetes Linked to Higher Adenoma Detection in 40s

Share this content:
DDW: Diabetes Linked to Higher Adenoma Detection in 40s
DDW: Diabetes Linked to Higher Adenoma Detection in 40s

(HealthDay News) – Patients aged 40 to 49 years with diabetes mellitus (DM) who undergo colonoscopy have a similar adenoma detection rate to those aged 50 to 59 years without DM, according to a study presented at the annual Digestive Disease Week, held from May 19 to 22 in San Diego.

Hongha T. Vu, MD, of the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective cohort study to investigate whether patients with DM should be screened for colorectal adenomas earlier than those without DM. A cohort of 125 participants with DM undergoing first colonoscopy at ages 40 to 49 were date-of-exam and gender matched to cohorts of participants aged 40 to 49 and 50 to 59 years without DM.

The researchers found that the adenoma detection rate was 14.4, 30.4, and 32.0% in those aged 40 to 49 without DM, 40 to 49 years with DM, and 50 to 59 without DM, respectively. Compared to 40- to 49-year-olds without DM, the adenoma detection rate was significantly higher for those aged 40 to 49 with DM (odds ratio [OR], 2.6; adjusted OR, 15.3) and for those aged 50 to 59 years without DM (OR, 2.8; adjusted OR, 14.1). The adenoma detection rate was not statistically significantly different for those aged 40 to 49 with DM and those aged 50 to 59 without DM.

"Our data may have important public-health implications given the rapidly rising incidence of DM, and suggest that consideration be given to modifying current screening guidelines by suggesting that patients with type 2 DM begin screening earlier than age 50," the authors write.

Press Release
More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs